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Abstract
Respiratory syncytial virus (RSV) is one of the major pathogens responsible for lower respiratory tract infections
(LRTI) in young children, the elderly, and the immunosuppressed. Currently, there are no antiviral drugs or vaccines
available that effectively target RSV infections, proving a significant challenge in regards to prevention and
treatment. An in-depth understanding of the host-virus interactions that underlie assembly and budding would
inform new targets for antiviral development.
Current research suggests that the polymerised form of actin, the filamentous or F-actin, plays a role in RSV
assembly and budding. Treatment with cytochalasin D, which disrupts F-actin, has been shown to inhibit virus
release. In addition, the actin cytoskeleton has been shown to interact with the RSV matrix (M) protein, which plays
a central role in RSV assembly. For this reason, the interaction between these two components is hypothesised to
facilitate the movement of viral components in the cytoplasm and to the budding site. Despite increases in our
knowledge of RSV assembly and budding, M-actin interactions are not well understood. In this review, we discuss
the current literature on the role of actin cytoskeleton during assembly and budding of RSV with the aim to
integrate disparate studies to build a hypothetical model of the various molecular interactions between actin and
RSV M protein that facilitate RSV assembly and budding.
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Background
Respiratory syncytial virus (RSV) is the major cause of
lower respiratory tract disease in infants and young chil-
dren [1] and a major viral agent responsible for respiratory
tract disease in immunosuppressed individuals and the
elderly [1]. In 2009, the World Health Organisation esti-
mated that globally there are 64 million annual RSV cases
leading to 160,000 deaths (http://apps.who.int/vaccine_re-
search/diseases/ari/en/index2.html). Antiviral drugs and
vaccines that effectively target RSV infections are cur-
rently unavailable, representing a significant challenge in
regards to RSV disease prevention and treatment [2].
Virus infection is initiated via inoculation of the nose or
eyes which can occur through direct contact or inhalation
of airborne infectious particles. This results in viral repli-
cation in the nasopharynx over 4–5 days, the virus
occasionally spreads to the lower respiratory tract over the
next few days [3].
RSV is a member of the Pneumoviridae family, which
consists of two genera, Metapneumovirius and Orthop-
neumovirus, with RSV belonging to the latter [4]. The
virion is pleomorphic, being either spherical or filament-
ous [5]. Similar to the closely related Paramyxoviruses,
the negative sense RNA genome of RSV is tightly encap-
sidated within the nucleocapsid, which is composed of
nucleocapsid protein N, the RNA polymerase L and its
cofactor phosphoprotein P, as well as the M2-1 protein;
external to the nucleocapsid is a layer of matrix (M) pro-
tein which acts as a bridge between the nucleocapsid
and the lipid bilayer envelope. Embedded in the enve-
lope are the fusion (F), large (G) and small hydrophobic
(SH) glycoproteins. M2-2 and two non-structural pro-
teins NS1 and NS2 are not found in the virion in any
significant amount but have important roles in the RSV
replication cycle [5–12]. Figure 1 shows the genome or-
ganisation of prototypic members of the Paramyxovirus
and Pneumovirus families.
* Correspondence: Reena.Ghildyal@canberra.edu.au
Respiratory Virology Group, Health Research Institute, Faculty of Education,
Science, Technology and Mathematics, University of Canberra, Canberra
2617, Australia
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shahriari et al. Virology Journal  (2016) 13:161 
DOI 10.1186/s12985-016-0618-z
The mechanisms that drive assembly and budding dif-
fer among the viruses and thus, no particular mechan-
ism can be assumed for all members. However, in all
cases, the M protein drives coordinated interplay be-
tween viral structural components to facilitate assembly
of infectious progeny. For this reason, M protein is con-
sidered as the key organizer of virus assembly [13]. Not
only does the M protein interact with viral glycoproteins
and the nucleocapsid, it also interacts with the cytoskel-
eton in infected cells [14], and bundles of actin microfil-
aments in epithelial cells and fibroblasts are altered
during infection. Additionally, similar to members of
Paramyxoviridae family, RSV has been shown to require
actin or tubulin or both for effective transcriptase activ-
ity in vitro [15, 16] underscoring the importance of host
cell cytoskeleton in Orthopneumovirus lifecycle.
Despite at least two decades of sporadic research
investigating cytoskeleton involvement in RSV infection,
the role of cytoskeleton in RSV assembly and/or budding
is still unclear. In this review we bring together our
current knowledge and understanding of the role of the
cytoskeleton in RSV infection, drawing on literature on
such interactions in other related viruses; the aim being
to integrate diverse studies in order to form a rational
informed model of RSV-cytoskeleton interactions.
Virus life cycle
The infectious cycle of RSV follows a similar route to
the paramyxovirus lifecycle, however, with several differ-
ences, which are detailed in following sections. The
paramyxovirus life cycle begins upon attachment of the
virus to the host cell and fusion of the viral membrane
to the host cell membrane facilitated by the two major
glycoproteins, the attachment protein (H, HN, or G
depending on the virus; see Fig. 1) and the F protein
(Fig. 1). Membrane fusion follows and precedes the
Fig. 1 Genome organisation of Paramyxovirus and Pneumovirus genera. The nucleoprotein (N), phosphoprotein (P), matrix (M) protein, fusion (F)
protein, and RNA-dependent RNA polymerase (L), are conserved in this order among the viruses belonging to both families. The attachment
protein (H, HN, or G), differs amongst the viruses depending on haemagglutinin (H) presence, haemagglutinin-neuraminidase (HN) activity, or
neither H present or HN activity (G). Only three genera contain the small hydrophobic SH protein, while both genera belonging to the
Pneumovirinae subfamily (Pneumovirus and Metapneumovirus) also possess M2, NS1, and NS2 genes. However, gene positions vary between
the Pneumovirus and Metapneumovirus genera
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release of the viral genome into the cytoplasm [17].
Upon release, the viral genome undergoes primary tran-
scription, followed by translation and replication to form
new genomes. The newly synthesised viral genomes are
associated with the N protein and wrapped around a nu-
cleocapsid core containing L and P proteins [18]. This
process forms the ribonucleoprotein complex (RNPs),
which are then transported to the plasma membrane
where interaction with the membrane glycoprotein com-
plex takes place, facilitated by the M protein. At the
plasma membrane, the RNPs, the M protein, and the
glycoproteins form the paramyxovirus particles, which
are then released through membrane scission [13].
RSV entry
Of the three RSV envelope glycoproteins, only F is es-
sential for attachment and entry although G deleted
strains are highly attenuated in vivo [19]. Glycosamino-
glycans (GAGs) are cell surface receptors implicated in
RSV attachment in cell culture, as well for many other
viruses [20, 21]. Interestingly, nucleolin has been shown
to function as an entry receptor for RSV via F glycopro-
tein; non-permissive cells become susceptible to RSV in-
fection when transfected to express human nucleolin
[22]. As nucleolin is ubiquitously expressed, there is
probably another receptor that determines tropism. Of
direct relevance to this review is the fact that cell surface
nucleolin mediates internalisation of ligands via its inter-
action with the actin cytoskeleton [23]. Entry of RSV
genome has been described as F mediated fusion of viral
envelope and host cell membrane (Fig. 2), though some
evidence implicates clathrin mediated endocytosis in the
entry process, independent of endosomal acidification
[24, 25].
RSV transcription and translation
The minimum protein requirement for RSV transcrip-
tion is N, P and L. In infected cells, these proteins are
found in cytoplasmic inclusions, which also contain viral
RNA of both polarities and are presumed to be sites of
transcription [26]; recent studies suggest that inclusions
are not structurally or functionally homogenous [27]
Fig. 2 Paramyxovirus Lifecycle. Attachment to the host cell membrane initiates the viral lifecycle and entry occurs by the release of the viral
genome into the cytoplasm. The negative-sense RNA genome undergoes primary transcription to produce mRNAs. The viral genome is replicated
in a two-step process catalyzed by the viral polymerase (composed of phosphoprotein (P) and large (L) protein components) where antigenome
intermediates are produced from genomic templates before the production of negative-sense genomes. The helical nucleocapsid is formed by
association of the newly synthesised nucleoprotein (NP) with the nascent genomic RNA. This newly formed structure then interacts with the
RNA-dependent RNA polymerase complex (RNPs). RNPs are transported to the plasma membrane by M protein where they interact with surface
glycoproteins for assembly, before membrane scission and release of virus particles. The figure was generated using Adobe Illustrator
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being implicated in innate response to RSV infection.
Transcription results in 10 capped, methylated and poly-
adenylated mRNAs which are translated by host cell ma-
chinery. Each gene is flanked by a gene-start (GS) and
gene-end (GE) sequence [28, 29]. A promoter at the 3’
end of the genome acts as the only attachment site for
the polymerase complex [5]. Genes are then transcribed
sequentially from 3’ to 5’ end. However, due to polymer-
ase drop off at intergenic regions, there is a gradient of
expression, with genes at the 3’ end expressed at higher
levels than genes at the 5’ end. Hence, proteins that the
virus needs early and in greater numbers such as the
interferon antagonists, non-structural proteins NS1 and
NS2, are produced much more than proteins needed in
small supply such as the polymerase L protein. The end
of the M2 gene and start of the L gene overlap by 68 nu-
cleotides. The polymerase complex overcomes this diffi-
culty by backtracking to the start of the L gene after
completing transcription of M2 [30]. This means that to
complete transcription of L, the polymerase complex
must “read through” the GE sequence of M2, something
that it does not do in 90 % of cases [5]. The benefit of
this added complexity, if any, is uncertain. The M2 gene
also has the distinction of coding an additional protein
via a second, slightly overlapping open reading frame.
The M2-2 protein thus produced, has a non-structural
function and is dispensable for RSV replication [31].
RSV replication
Replication of new negative sense genomes requires the
production of a complete positive sense anti-genome as
an intermediate. This is accomplished with the polymer-
ase complex used for mRNA transcription but operating
in “read through” mode where GS and GE signals are
not recognised. The switch from transcription mode to
replication mode is of great interest to researchers but
little is known of this mechanism aside from M2-2 being
implicated. In cells infected with RSV without M2-2, the
level of viral mRNA was increased while genomic RNA
was decreased [31].
RSV assembly
Glycoproteins are translated and traffic through the
secretory pathway to the apical surface, while internal
virion proteins remain in the cytoplasm. Generation of
nascent RSV genomic RNA probably occurs in cytoplas-
mic inclusions. N and P form RNPs that associate with
the M protein, then traffic to the apical cell surface
where they meet the glycoproteins. At the cell surface,
viral proteins assemble into viral filaments that contain
both viral structural proteins and viral genomic RNA.
These filaments are thought to assemble into infectious
virion particles prior to separation from the cell surface,
since they can contribute to cell-cell spread of the virus
and morphologically resemble the filamentous form of
virions seen in electron micrograph studies of virus pro-
duced in polarized cells [5].
Although significant advances have been made in our
understanding of RSV assembly and elucidation of the
interactions between M and other viral proteins, our
current knowledge on how the RNPs and the envelope
glycoprotein complexes move from their cytoplasmic lo-
cation to the plasma membrane is still limited. Literature
from work with other viruses suggests a possible role for
the cytoskeleton in this movement. Specifically, proteins
associated with the actin network are implicated in RSV
budding [32–34].
RSV budding
As mentioned previously, RSV infection is restricted to
the superficial cells of the respiratory epithelium. In
keeping with this, budding in polarised epithelial cells
occurs at the apical membrane [35, 36] and preferen-
tially from lipid rafts [37, 38]. Viral budding occurs in a
Vps-4, ESCRT pathway independent manner resulting in
pleomorphic particles that can be spherical or filament-
ous [39]. Recent literature suggests that RSV proteins
are the main drivers of the formation of filamentous
virus, with cytoskeletal proteins playing a supporting
role [40].
It is likely that most, if not all, viruses utilise the cyto-
skeleton in some way. The most compelling argument to
support this is that while salts and gases are small
enough to diffuse through the cytoplasm, larger entities
such as mature virions and large subviral particles must
utilise the cytoskeleton transport system for active trans-
port [41]. Support for this idea comes from work that
examines the viscosity and diffusion properties of the
cytoplasm. It was found that the diffusion of hydrophilic,
electroneutral beads of 80 nm in radius was between
500 and 1000 fold lower in the cytoplasm than in aque-
ous solution [42]. Data from the same study has been
used to estimate that vaccinia virus would take 5 h to
diffuse a mere 10 μm in the cytosol [43]; however vac-
cinia virus movement from the juxtanuclear region to
the periphery is significantly faster (>2 μm/s).
In the following sections we provide a brief overview
of the cytoskeleton, followed by examples of its exploit-
ation by chosen viruses; finally, we present current lit-
erature on the role of cytoskeleton in RSV assembly and
budding and possible interactions with M protein.
The cytoskeleton
The cytoskeleton is composed of three different types of
protein filaments which in order of smallest to largest
are (filamentous) actin, intermediate filaments and mi-
crotubules. Apart from being the scaffolding that gives
the cell its shape and strength, the cytoskeleton has
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other important functions. Not only does the cytoskel-
eton play a role in positioning and holding organelles in
place, it also allows for cell locomotion. In addition,
events such as cytokinesis and the movement of chro-
mosomes during anaphase rely on the cytoskeleton and
its associated molecular motors [44].
Actin
Actin is the most abundant cytoskeletal protein in eu-
karyotes and typically accounts for 5 to 10 % of total
protein [44]. Actin monomers (G-actin) assemble into
filaments (F-actin) with a distinct polarity; they have a
fast growing barbed end and a slow growing pointed end
[45]. The implication of this polarity is that when used
as a track for intracellular transport, motor proteins only
carry cargo in a specific direction. Actin filaments can
be arranged into a variety of linear bundles and two-
dimensional arrays, or three-dimensional gels [46]. Nu-
merous actin binding proteins regulate the polymerisa-
tion and organisation of F-actin and it is these proteins
that are sometimes the target of viral manipulation [32].
Although actin is present throughout the cytoplasm it is
most abundant at the periphery of the cell which is
where polar actin networks such as filopodia, lamelli-
podia and pseudopodia reside [47]. The peripheral actin
network is sometimes referred to as the actin cortex.
The actin cortex is generally arranged with plus ends fa-
cing outward and is the key player in cell motility which
is based on filament assembly and the action of myosins
[48]. The actin cortex has been proposed to be an obs-
tacle to viral entry [49] and this might be why some vi-
ruses use the endocytic pathway which easily crosses the
actin cortex [46]. Regulated binding to actin filaments
can control the localisation of viral proteins such as the
nucleoprotein of influenza virus [50].
Microtubules
Microtubules are the largest of the cytoskeleton fila-
ments and like actin filaments they display a distinct
polarity as well as a fast growing end and a slow
growing end. Microtubules are composed of dimers of
α-tubulin and β-tubulin arranged head to tail length-
wise and 13 side by side around a hollow core [44].
Most of the microtubules in a cell radiate outward
from a microtubule organising centre (MTOC), also
called a centrosome which is usually located near the
nucleus. Microtubules extend from the MTOC with
plus ends facing outward. Different cell types such as
polarised epithelial cells and neurons can have specia-
lised microtubule networks. Microtubules in axons
are longitudinally arranged with plus ends pointing
toward the axon terminal and minus end pointing to-
ward the soma [51] while in polarised epithelial cells
microtubules are arranged with plus ends pointing
toward basal membrane and minus ends pointing to-
ward the apical membrane [46]. The main role of mi-
crotubules in viral infection is to provide the tracks
that the motor proteins kinesin and dynein use for
long range transport of viral proteins, nucleocapsids
and enveloped virions. This role has been described
previously in many reviews [41, 52, 53], and will be
described briefly in this review.
Intermediate filaments
Intermediate filaments have several important differ-
ences to F-actin and microtubules. They exhibit no
treadmilling behaviour and have no polarity [44]. The
general role of intermediate filaments is more of a struc-
tural support role and to provide scaffolding for the lo-
calisation of cellular processes, especially the nucleus,
around which intermediate filaments form a ring. They
are composed of over 65 different proteins enabling
intermediate filaments to be turned to a variety of differ-
ent purposes [44]. Intermediate filaments are known to
be disassembled or rearranged by viral proteases [54,
55]. This may serve the virus by removing a barrier to
free diffusion or it may weaken the cell enough to en-
hance cell lysis and release of viral progeny.
Molecular motors
Motor proteins use ATP hydrolysis to power their move-
ment along cytoskeleton filaments. If the motor protein
is fixed, it moves the filament and if the motor protein is
not fixed, it moves cargo along the filament. Myosins
transport cargo along actin filaments, whereas kinesins
and dynein move along microtubules. There are 18 clas-
ses of myosin, grouped according to homologous se-
quences in the tail domain which determines cargo
specificity. The most well-known and best studied is my-
osin II, the myosin responsible for muscle contraction.
Most classes of myosin are plus end directed motors
with the exception of myosin VI and possibly IXb, which
are minus end directed [46]. Kinesins and dyneins trans-
port membrane vesicles, macromolecules, organelles and
viral particles/proteins toward the plus end and minus
end, respectively, of microtubules.
The cytoskeleton in virus assembly
The host cell cytoskeleton plays an important role in as-
sembly and budding of several viruses across different
families.
Vaccinia virus
Vaccinia virus is a large double stranded DNA virus that
exploits actin and tubulin cytoskeletons to ensure that
its components are at the right place at the right time
for optimal infectious virus production. After entry, viral
cores use microtubules to move centrally where viral
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gene expression and formation of intracellular mature
virus (IMV) occur [56]. The IMVs now use microtubules
to move from viral factories to areas near the MTOC
where they acquire an envelope from the trans-Golgi
network or early endosomes and become intracellular
enveloped virions (IEV) [57]. IEV is the intermediate be-
tween IMV and cell-associated enveloped virions (CEV).
After acquiring the envelope, IEVs again use microtu-
bules but this time in the opposite direction as they
travel toward the periphery where they fuse with the
plasma membrane and are exposed on the outside of
the plasma membrane as CEV [58]. The next stage of
the vaccinia lifecycle illustrates an impressive subver-
sion of the actin cytoskeleton by the virus. CEV are
able to induce the polymerisation of actin, creating
protrusions known as actin tails that facilitate cell to
cell spread by pushing the exposed CEV into adjacent
cells [59].
Poliovirus
The positive sense RNA virus Poliovirus exploits the
actin cytoskeleton during infection; after binding, polio-
virus is internalized through an actin dependent pathway
followed by rapid release of the RNA [60]. Interestingly,
poliovirus was shown to move rapidly in the cytoplasm
with unusually high speeds, independent of microtu-
bules, but both ATP- and actin-dependent, suggesting
an active transport mechanism. However, the viral tra-
jectory and speed could not be accounted for by trans-
port along microfilaments and a model wherein
poliovirus induces changes in the activity of motor pro-
teins was proposed [61].
Herpesvirus
Neurotropic viruses such as herpes simplex viruses
(HSV) need to travel long distances within neurons.
HSV takes control over the cytoskeleton early in infec-
tion by remodelling the cortical actin cytoskeleton [62].
The purpose of this remodelling may be to prepare the
cell for efficient exit of virus later in infection [63]. Viral
capsids interact directly with dynein [64], in order to
travel the long distance to reach the nucleus. After en-
tering the nucleus, HSV genomes are transcribed, repli-
cated and packaged into new capsids. HSV induces the
formation of actin in the nucleus even in cells where
there is normally no nuclear actin [65]. Newly formed
capsids recruit myosin for active transport along these
actin filaments to the periphery of the nucleus [66]. Sev-
eral HSV proteins have been shown to induce conform-
ational changes in the nuclear lamina that may facilitate
nuclear egress [67, 68]. Virions then travel back down
the axon to the site of exit via microtubule transport
through the recruitment of kinesin [52].
Cytoskeleton in paramyxovirus, pneumovirus life
cycle
Entry
The host actin cytoskeleton plays an important role in
the life cycle of paramyxoviruses [15, 69, 70]. The actin
network creates a physical barrier against the invading
virus, which must be overcome to enable productive in-
fection [71]. This is made possible by the remodelling of
the actin skeleton that is stimulated during paramyxo-
virus (and RSV) infection. Bundles of microfilaments are
established through the formation of stress fibres [71]
regulated by the Rho-family of GTPases, which play a
role in controlling signal transduction pathways that
generate changes in the actin cytoskeleton [71, 72] and
are involved in influencing the assembly or disassembly
of F-actin [73].
Assembly
Several paramyxoviruses, including Sendai (SeV) and
measles virus (MeV), utilise vesicles that contain key
regulators of microtubule transport such as Rab11A.
The apical recycling endosome (ARE) pathway, that
Rab11 endosomes are associated with, is important for
the transport of proteins in polarized cells [13, 39, 74].
Although this notion suggests that Rab11A is required
only in polarized cells, it has been demonstrated that the
requirement is for both polarized and non-polarised cells
with regards to SeV assembly [39]. In MeV infection,
Rab11A is required only for virus production in polar-
ized cells and not for RNP transport [75]. The presence
of a dominant-negative form of the Rab11-interacting
protein myosin Vb (MVb), results in reduced RSV as-
sembly at the apical membrane. Of interest is Rab11-
FIP2 (FIP2), another Rab11 interacting protein that may
be involved in formation of filamentous virions [39].
Parainfluenza virus 3 (hPIV3) requires microfilaments
for replication; however, its assembly is dependent on
microtubules. This is in contrast to SeV and MeV where
assembly depends on microfilaments as well as microtu-
bules [75].
Budding
Cytoskeletal components are also involved in the bud-
ding of parvirus particles [13, 76, 77]. Actin involvement
in budding was first discovered through studies under-
taken on SeV and MeV particles, where large quantities
of actin were detected in purified preparations of the
two viruses. Studies on SeV have suggested that expres-
sion of M or F allows for the production of virus like
particles (VLPs) that contain actin; both M and F pro-
teins are required for budding. Significantly, sequences
within M and F proteins resemble actin-binding
domains [78, 79]. Mutations in the actin binding do-
mains of SeV F result in significant reduction in VLP
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production suggesting that SeV F protein binding to
actin is required for budding to take place [13].
Cytochalasin D, a specific inhibitor of actin polymer-
isation, inhibits release and reduces infectivity as well as
entry of paramyxoviruses [71, 75]. As the microfilament
network plays a role in the trafficking of RNP com-
plexes, it is not surprising that virus release is affected
by such drugs [13, 71]. However, treatment of hPIV3 in-
fected A549 alveolar carcinoma lung cells with cytocha-
lasin D had no effect on virus release. In contrast,
microtubule depolymerisation drugs seemed to have
more of a inhibitory effect on hPIV3 virus release [75].
Therefore, it is evident that each virus utilizes the cyto-
skeleton differently, however, the cytoskeleton does play
an important role in replication, assembly, transporta-
tion, and budding of paramyxoviruses (Table 1).
Paramyxovirus M protein and cytoskeleton
The interaction of Newcastle disease virus (NDV) and
SeV M proteins with actin filaments is important during
virion maturation [70]. Expression of SeV M protein is
essential for the actin restructuring that is observed dur-
ing infection and virion release. MeV M-RNP complexes
use the F-actin network to move to the plasma mem-
brane; however, actin dynamics are required for viral
budding [69].
Cytoskeleton in RSV infection
RSV is known to interact with the cytoskeleton in sev-
eral ways and at various stages throughout its life cycle.
In addition to transcriptional regulation, the cytoskel-
eton is also likely to be involved in the directional move-
ment of RSV components. Live video microscopy
showing filamentous virus budding from the same re-
gion of cell membrane at a rate of several virions per mi-
nute suggests directed transport [80]. The picture that
has emerged so far seems to be that of the three cyto-
skeleton components, actin is the most important in
RSV pathogenesis. However, the microtubule inhibitor
nocodazole has been shown to reduce RSV titre by al-
most as much as cytochalasin D (9 fold reduction com-
pared to 10 fold reduction) [81]. In the following
sections, we present an overview of the known interac-
tions, focussing on M and F proteins.
Transcription
Actin is present as an internal component in purified
RSV virions [34] and antibodies against actin inhibit
RSV transcription [33]. In a study using microarrays to
analyse host gene expression in RSV infected cells, it
was found that five genes associated with the cytoskel-
eton were upregulated shortly after infection [82]. There
is evidence that RSV is indirectly involved with the cyto-
skeleton through interaction with actin associated
proteins. Profilin, an actin-modulatory protein, has a
significant role in RSV transcription [15, 32]. Although
the RSV polymerase complex is able to mediate tran-
scription in the absence of any cellular factors, actin is
required for optimal activity. Current understanding of
paramyxovirus transcription suggests that monomeric
actin is required for transcriptase activity; the presence
of actin in the virions likely reflects the involvement of
actin in RSV transcription [75].
Assembly
The cytoskeleton has been suggested to play a role in
transport of RNPs to RSV budding sites; RNPs display a
myosin motor driven directional movement on the actin
cytoskeleton [77]. Using live cell tracking of RNPs in
cells infected with a recombinant RSV that expressed
GFP, Santangelo and Bao [77] showed that RNPs move
from the vicinity of filamentous virus at the apical
surface and formed circular, inclusion-like structures in
the cytoplasm on treatment with cytochalasin D. Im-
portantly, myosin colocalised strongly with the virus
filaments but not with cytoplasmic inclusion-like struc-
tures; suggesting myosin’s role in movement of RNPs to
the budding site. Given the key role of M and actin in
Table 1 Requirement of cytoskeletal components in paramyxovirus replication and assembly
Virus Cytoskeletal component Virus lifecycle stage Reference
Measles virus Tubulin Replication [76, 95]
Microfilaments Budding
Sendai virus Actin Transcription [71, 76]
Tubulin Transcription
Microfilaments Assembly
Respiratory syncytial virus Actin Transcription [33, 82, 84, 96, 97]
Tubulin Transcription
Microfilaments Entry, Assembly
Human Parainfluenza virus type 3, 5 Actin Transcription [98, 99]
Microfilaments Assembly
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RSV assembly, it is important to understand the interac-
tions between M and actin which underlie M’s role as
facilitator and bringing together the RNP and envelope
glycoproteins for virus assembly at the plasma
membrane.
Budding
That microfilaments are required for optimal RSV bud-
ding and release is shown by the fact that virus release is
inhibited by the microfilament destabilizing drug cyto-
chalasin D, as mentioned previously [34, 75, 83].
In view of the connection between lipid rafts and the
actin network [84], and that RSV buds from lipid raft
domains of the plasma membrane [37, 85], myosin-
driven transport likely also plays a role in RSV budding
and release [77]. Increased F-actin is also observed at
the lipid raft domain budding sites of human metapneu-
movirus [86], suggesting assembly/budding mechanism
similar to RSV. Actin-modulatory proteins profilin and
RhoGTPase are associated with RSV budding. As an
actin-modulatory protein, profilin plays a role in pro-
moting the formation and stabilization of stress fibres.
In RSV infected cells, it has a role in virion morphogen-
esis and cell fusion in addition to enhancing the tran-
scriptase activity [71]. RhoA GTPase has a variety of
functions in the cell, including organisation of the actin
cytoskeleton; blocking its action has a deleterious effect
on RSV budding [87, 88] and RSV infection results in
activation of RhoA, leading to rearrangement of the
actin cytoskeleton. Interestingly, inhibition of RhoA
leads to virus filaments adopting a more spherical par-
ticle morphology rather than a blunted one [89].
Phosphoinositide-3-kinase (PI3K) signalling, which has
an important role in activation of F-actin associated sig-
nalling pathways that lead to structural changes in the
F-actin network during infection, has a role in the or-
ganisation of RSV proteins at assembly sites [83]. In
addition, PI3K activity may be involved in the formation
of pneumovirus filaments that enable cell-to-cell viral
spread [71, 89].
Although cytoskeletal components are clearly associ-
ated with RSV assembly and budding, studies under-
taken on the effects of actin or tubulin disruption have
suggested that RSV may assemble into filaments using a
mechanism that does not depend on the host cytoskel-
eton [89].
RSV F protein
The F protein is essential for assembly and budding
of RSV. The F-protein cytoplasmic tail (FCT) has
been shown to be required for efficient replication as
studies on viruses lacking this domain have effectively
demonstrated a 100- to 1000-fold decrease in viral
titres. RSV infection induces the formation of
filaments, which have been shown to contain the viral
proteins F, M, N, and P [89]. The formation of RSV
filaments appears to depend on the FCT, especially a
specific phenyalanine (Phe) residue at position 22
[13, 89, 90]. Interestingly, a mutation in Phe22 leads
to the inability of RSV F to recruit viral proteins into
VLPs and, thus, form filaments [89]. Therefore, the F
protein plays a role in coordinating the assembly of
the virus filaments at the cell surface [13, 89, 90].
The F protein is key to the formation of syncytia that
are characteristic of RSV infection. F interacts directly
with RhoA in vitro and inhibition of this interaction in
infected cells results in abrogation of syncytia formation
[39]; clearly, RhoA-F interaction drives cell to cell spread
of RSV.
RSV M and F protein
The minimum RSV assembly complex contains F, M
and the RNP core [91] and is formed in cytoplasmic
inclusions [90]. Although cytoplasmic inclusions are
characteristic of RSV infected cells, their role in in-
fection is not completely understood [27, 83, 89]. It
has been suggested that inclusions are sites of replica-
tion and/or transcription, sites for dead-end product
accumulation, or sites for morphogenic intermediates
[27]. RSV M protein associates with cytoplasmic in-
clusions late in infection through its interaction with
the M2-1 protein and has been suggested to play a
role in the switch between transcription and assembly
[92, 93]. One study has effectively shown that both M
and F protein association with cytoplasmic inclusions
is critical in the assembly process, a step preceding
filamentous virion formation, supporting the idea that
viral filaments are formed or initiated from inclusions
acting as scaffolds [90]. These associations with inclu-
sions have been shown to be related to FCT-
dependent changes, where increased amounts of F
protein accumulated at the inclusions in the absence
of FCT. In addition, the proportion of M associated
with inclusions has been shown to be low when there
is an abundance of filamentous (as opposed to spher-
ical) virus. In turn, the M is increased in the cyto-
plasm in studies that involved the deletion of FCT,
suggesting that the cytoplasmic M requires associ-
ation with inclusions in order for incorporation into
filaments [90].
F protein targets virus components to the lipid rafts,
sites of virus budding [39, 89]. F and G glycoproteins as
well as M are sorted into lipid rafts in RSV infected cells
[38], with M forming structures suggesting an inter-
action with the cytoskeleton [89]. Inhibition of the Golgi
secreting pathway prevents M being sorted into lipid
rafts. M and F are co-localised to lipid rafts in cells co-
expressing the two proteins and in RSV infected cells.
Shahriari et al. Virology Journal  (2016) 13:161 Page 8 of 11
RSV M protein and actin
The M protein has been suggested to interact with actin for
assembly and budding of RSV virions [94]. Both the M
protein and the actin cytoskeleton have previously been
described to individually play a role in the assembly of RSV.
As mentioned, the M protein interacts with the RNP com-
plex to inhibit the transcriptase activity probably in prepar-
ation for packaging [92]. As M also interacts with the host
cytoskeleton, studies have suggested that there is an
important role for this cellular component in RNP transport
to the plasma membrane [77]. Current knowledge suggests
that the M-containing complex is anchored onto the micro-
filament network that the nucleocapsid takes advantage of
to reach RSV budding sites [89, 90]. The formation of fila-
mentous virus is probably mediated through the interaction
between RNPs, envelope glycoprotein complex and the
plasma membrane by association of M with FCT [6, 37].
Conclusions: proposed model for the role of actin
in RSV assembly and budding
Based on current literature on RSV as discussed above,
it appears that the RNPs of RSV use microfilaments as a
means of transport to reach assembly sites as shown for
the closely related paramyxoviruses (Fig. 3); this move-
ment may be mediated by M’s interaction with microfila-
ments, ensuring that only mature RNPs move to the
plasma membrane. F protein probably also associates
with the complex at this time mediated by M-FCT inter-
action to target the complex to the lipid rafts. At the cell
surface assembly site, M-RNPs (+/− F) may associate
with envelope glycoproteins via M’s self-oligomerising
activity that allows it to bind to the M-F/G complexes
(formed through M’s interactions with cytoplasmic tail
of G, and F) forming the budding particle. FCT functions
to engage RhoA, leading to extension of the virus fila-
ments, followed by an as yet unknown scission mechan-
ism that releases the RSV particles.
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